Protech Home Medical to Virtually Attend the Canaccord Genuity 40th Annual Growth Conference on August 11th – 13th

Protech Home Medical Corp. a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that members of its management team will be presenting at the upcoming Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 to 13, 2020. For more information, please visit https://www.canaccordgenuity.com/capital-markets/about-us/events/.

Webcasted Presentation

Event: Canaccord Genuity 40th Annual Growth Conference
Date:
Thursday, August 13, 2020 
Time:
8:30am EDT 

The live webcast of the presentation will be available by visiting the investors’ section of the Company’s website at www.protechhomemedical.com. The webcast will also be available for replay on the Company’s website following the event.

“We are excited to attend this well-known and prestigious investor conference and have plans to be very active on the capital markets front including attending U.S. and Canadian based investor conferences throughout the remainder of 2020,” commented Greg Crawford, CEO and Chairman of Protech. “On the heels of our recent financing, which provided us with the strongest balance sheet in our history, and as we continue to operate at an extremely high level in the midst of the COVID-19 pandemic, we look forward to sharing the Protech story with a broader array of institutional and retail investors.”

ABOUT PROTECH HOME MEDICAL

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

For further information please visit our website at www.protechhomemedical.com, or contact:

Cole Stevens
VP of Corporate Development
Protech Home Medical Corp.
859-300-6455
cole.stevens@myphm.com

Gregory Crawford
Chief Executive Officer
Protech Home Medical Corp.
859-300-6455
investorinfo@myphm.com

See Campaign: http://myphm.com
Contact Information:
Cole Stevens
VP of Corporate Development
Protech Home Medical Corp.
859-300-6455
cole.stevens@myphm.com

Tags:
, Wire, Disclosure Newswire, United States, English

image

Contact Information:

Cole Stevens
VP of Corporate Development
Protech Home Medical Corp.
859-300-6455
cole.stevens@myphm.com

Asiya